About ANMI
ANMI is a company based in Herstal (Belgium) founded in 2015 was acquired by Telix Pharma in November 2018. The company has 20 employees. ANMI offers products and services including Theranostic Radiopharmaceuticals and Radiopharmaceutical Services. ANMI operates in a competitive market with competitors including Laurus Labs, Sterling Pharma Solutions, Provepharm Life Solutions, Symbiotec and Jubilant Pharma, among others.
- Headquarter Herstal, Belgium
- Employees 20
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website anmi.be
- Social LinkedIn
- Acquired by Telix Pharma (Nov 2018)
- Legal Name Telix Innovations
- Net Profit$101.18 K (USD)-64as on Dec 31, 2021
- EBITDA$1.62 M (USD)379as on Dec 31, 2021
- Investors
- Employee Count20
- Acquired byTelix Pharma
(Nov 2018)
Products & Services of ANMI
ANMI offers a comprehensive portfolio of products and services, including Theranostic Radiopharmaceuticals and Radiopharmaceutical Services.
Enables scalable synthesis for hospital-based radiopharmaceutical production.
Facilitates daily ease of radiopharmaceutical manufacturing processes.
Investors in ANMI
ANMI has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Telix Pharmaceuticals.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Theranostic radiopharmaceuticals are developed for cancer imaging and therapy. | 2015 | telixpharma.com | Melbourne, Australia |
Investor details for ANMI
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of ANMI
2 dated milestones of ANMI across 3 years, from founding to its latest funding, stage changes and deals.
- Founded ANMI is founded.
- Exit Acquired by Telix Pharma.
Competitors of ANMI
ANMI operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Sterling Pharma Solutions, Provepharm Life Solutions, Symbiotec and Jubilant Pharma, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| sterlingpharmasolutions.com | 2016 | Dudley, United Kingdom | – | 560 | Contract development, manufacturing, and analytical services for APIs are offered. | |
| provepharm.com | 1998 | Marseille, France | $145.93M | – | APIs and drug products are developed and valorized in pharmaceuticals. | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| jubilantpharma.com | 1978 | Noida, India | – | – | Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. | |
| apicore.com | 2004 | Somerset, United States | $720,118 | 518 | APIs are manufactured and custom synthesis services are provided. | |
| sequent.in | 2002 | Bengaluru, India | – | – | APIs are developed and manufactured for therapeutic areas. | |
| bellenchem.com | 2007 | Beijing, China | $52.56M | – | APIs and intermediates are researched and manufactured, specializing in heterocycles. |
Detailed competitors of ANMI
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of ANMI
The website of ANMI (anmi.be) receives about 4.8K visits a month.
- Monthly visits4.8K
▼ 1.1% vs previous month
Latest news on Anmi
Complete news archive for ANMI
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to ANMI
10 companies that operate in the same segment as ANMI (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about ANMI
ANMI was founded in 2015.
ANMI is headquartered in Herstal, Belgium. It is registered at Herstal, Liege, Belgium.
ANMI has 20 employees.
ANMI was founded in 2015 and is located in Herstal, Belgium. Operations are centered on contract development and manufacturing as a CDMO within the pharmaceutical sector. Emphasis is placed on the synthesis of active pharmaceutical ingredients (APIs). Services are extended to clients requiring specialized chemical processes, with activities based in Belgium to support European pharmaceutical needs.
ANMI's top competitors include Laurus Labs, Symbiotec and Sterling Pharma Solutions.
ANMI offers Theranostic Radiopharmaceuticals and Radiopharmaceutical Services.
ANMI has 1 investor. Key investors include Telix Pharmaceuticals.
ANMI operates through Telix Innovations.
Yes. ANMI was acquired by Telix Pharma in November 2018.